Y-mAbs Therapeutics, Inc. Financing Cash Flow
Y-mAbs Therapeutics, Inc. reported Financing Cash Flow of $446.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $332.00K, a 81.11% decline year-over-year.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $114.00K, a 80.61% decline year-over-year.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $986.00K.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $979.00K.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $4.31M, a 4211.00% increase from fiscal 2023.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $100.00K, a 19.05% increase from fiscal 2022.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $84.00K, a 99.92% decline from fiscal 2021.
- Y-mAbs Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $108.31M, a 5304.89% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $446.00K 10-Q · filed 2025-08-08 | $1.43M derived: sum of 3 quarters · filed 2025-08-08 | $2.41M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $114.00K 10-Q · filed 2025-05-13 | $1.10M derived: sum of 2 quarters · filed 2025-05-13 | $2.08M derived: sum of 3 quarters · filed 2025-05-13 | $3.84M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.97M derived: sum of 2 quarters · filed 2025-03-04 | $3.72M derived: sum of 3 quarters · filed 2025-08-08 | $4.31M 10-K · filed 2025-03-04 |
| 2024-09-30 | $979.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.74M derived: sum of 2 quarters · filed 2025-08-08 | $3.33M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.35M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $588.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $100.00K 10-K · filed 2025-03-04 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $52.00K derived: sum of 2 quarters · filed 2024-02-29 | $52.00K derived: sum of 3 quarters · filed 2024-02-29 | $84.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $52.00K derived: sum of 2 quarters · filed 2023-11-13 | $84.00K 10-Q · filed 2023-11-13 | $184.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $32.00K 10-Q · filed 2023-08-10 | $132.00K derived: sum of 3 quarters · filed 2023-08-10 | $380.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-08 | $132.00K derived: sum of 2 quarters · filed 2023-05-08 | $380.00K derived: sum of 3 quarters · filed 2023-05-08 | $511.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $348.00K derived: sum of 2 quarters · filed 2023-03-30 | $479.00K derived: sum of 3 quarters · filed 2023-03-30 | $108.31M 10-K · filed 2023-03-30 |
| 2021-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $379.00K derived: sum of 2 quarters · filed 2022-11-07 | $108.21M 10-Q · filed 2022-11-07 | $109.63M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $107.97M 10-Q · filed 2022-08-08 | $109.39M derived: sum of 3 quarters · filed 2022-08-08 | $109.60M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $107.83M 10-Q · filed 2022-05-09 | $109.25M derived: sum of 2 quarters · filed 2022-05-09 | $109.47M derived: sum of 3 quarters · filed 2022-05-09 | $109.47M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.63M derived: sum of 2 quarters · filed 2022-03-01 | $1.63M derived: sum of 3 quarters · filed 2022-03-01 | $2.00M 10-K · filed 2022-03-01 |
| 2020-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $215.00K derived: sum of 2 quarters · filed 2021-11-04 | $585.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $370.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $370.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $134.70M 10-K · filed 2022-03-01 | |||
| 2018-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $100.53M derived: sum of 2 quarters · filed 2020-03-12 | $100.40M derived: sum of 3 quarters · filed 2020-03-12 | $98.76M 10-K · filed 2020-03-12 |
| 2018-09-30 | $102.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $102.25M derived: sum of 2 quarters · filed 2019-11-13 | $100.61M 10-Q · filed 2019-11-13 | $165.74M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$1.77M 10-Q · filed 2019-08-14 | $63.37M derived: sum of 3 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$1.64M 10-Q · filed 2019-05-10 | $63.50M derived: sum of 2 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $65.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $89.59M 10-K · filed 2019-03-22 | ||
| 2017-09-30 | $24.45M 10-Q · filed 2018-11-13 |